Compare · IIN vs MDLN
IIN vs MDLN
Side-by-side comparison of Intricon Corporation (IIN) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IIN and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 342.7x IIN ($129.6M).
- MDLN has hit the wire 20 times in the past 4 weeks while IIN has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for IIN).
- Company
- Intricon Corporation
- Medline Inc.
- Price
- $24.25+0.06%
- $33.80+0.58%
- Market cap
- $129.6M
- $44.40B
- 1M return
- -
- -19.55%
- 1Y return
- -
- -17.07%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 20
- Recent ratings
- 0
- 25
Intricon Corporation
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology, and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear-and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.
Latest IIN
- SEC Form 15-12B filed by Intricon Corporation
- SEC Form SC 13D/A filed by Intricon Corporation (Amendment)
- Intricon Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4: Giordano Nicholas A gifted 4,000 shares and returned 110,925 shares to the company, closing all direct ownership in the company
- SEC Form 4: Smith Philip Irving returned 16,327 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gorder Mark Stephen returned 373,709 shares to the company, closing all direct ownership in the company
- SEC Form 4: Rider Heather D. returned 9,121 shares to the company, closing all direct ownership in the company
- SEC Form 4: Huggenberger Raymond returned 11,154 shares to the company, closing all direct ownership in the company
- SEC Form 4: Pepski Kathleen P. returned 3,586 shares to the company, closing all direct ownership in the company
- SEC Form 4: Lutgen Annalee was granted 2,271 shares and returned 9,702 shares to the company, closing all direct ownership in the company
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)